Dendritic Cells Derived from Acute Myelogenous Leukaemia (AML) Have a Type 2 Cytokine Bias

Panoskaltsis, Nicki; Knight, Stella C.; Reid, Cecil D.L.

doi:10.1042/cs104053Pa

Skip Nav Destination

Article navigation

Conference Abstract| April 01 2003

Dendritic Cells Derived from Acute Myelogenous Leukaemia (AML) Have a Type 2 Cytokine Bias

Nicki Panoskaltsis;

Nicki Panoskaltsis

1Antigen Presentation Research Group, Faculty of Medicine, Imperial College London, Northwick Park Campus, Harrow

Search for other works by this author on:

This Site

PubMed

Google Scholar

Stella C. Knight;

Stella C. Knight

2Antigen Presentation Research Group, Faculty of Medicine, Imperial College London, Northwick Park Campus, Harrow

Search for other works by this author on:

This Site

PubMed

Google Scholar

Cecil D.L. Reid

3Department of Haematology, North West London Hospitals NHS Trust, Northwick Park Hospital, Harrow

Search for other works by this author on:

This Site

PubMed

Google Scholar

Author and article information

Publisher: Portland Press Ltd

Online ISSN: 1470-8736

Print ISSN: 0143-5221

2003

Clin Sci (Lond) (2003) 104 (s49): 53P.

https://doi.org/10.1042/cs104053Pa

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.

Portland Press

Registered address – First Floor, 10 Queen Street Place, London EC4R 1BE

Portland Press Tel
+44 (0)20 3880 2795
Portland Press Company no. 02453983

Biochemical Society Tel
+44 (0)20 3880 2793
Email: [email protected]

Biochemical Society Company no. 00892796
Registered Charity no. 253894
VAT no. GB 523 2392 69

Privacy and cookies
Accessibility

Dendritic Cells Derived from Acute Myelogenous Leukaemia (AML) Have a Type 2 Cytokine Bias

Article PDF first page preview

Get Access To This Article

Buy This Article

Cited By

Get Email Alerts

Open Access for all

CONNECT

EXPLORE

Cover Image

Dendritic Cells Derived from Acute Myelogenous Leukaemia (AML) Have a Type 2 Cytokine Bias

Article PDF first page preview

Sign in

Sign in to your personal account

Biochemical Society Member Sign in

Sign in via your Institution

Get Access To This Article

Buy This Article

Cited By

Get Email Alerts

Open Access for all

CONNECT

EXPLORE

This Feature Is Available To Subscribers Only